Real-life drug–drug and herb–drug interactions in outpatients taking oral anticancer drugs: comparison with databases
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s00432-021-03645-z.pdf
Reference61 articles.
1. Alkan A, Yaşar A, Karcı E et al (2017) Severe drug interactions and potentially inappropriate medication usage in elderly cancer patients. Support Care Cancer 25:229–236. https://doi.org/10.1007/s00520-016-3409-6
2. Askari M, Eslami S, Louws M et al (2013) Frequency and nature of drug-drug interactions in the intensive care unit. Pharmacoepidemiol Drug Saf 22:430–437. https://doi.org/10.1002/pds.3415
3. Babin M, Folliard C, Robert J et al (2019) Pharmaceutical consultations in oncology: implementation, one-year review and outlooks. Ann Pharm Fr 77:426–434. https://doi.org/10.1016/j.pharma.2019.05.001
4. Bahall M (2017) Prevalence, patterns, and perceived value of complementary and alternative medicine among cancer patients: a cross-sectional, descriptive study. BMC Complement Altern Med. https://doi.org/10.1186/s12906-017-1853-6
5. Beinse G, Reitter D, Segaux L et al (2020) Potential drug-drug interactions and risk of unplanned hospitalization in older patients with cancer: a survey of the prospective ELCAPA (ELderly CAncer PAtients) cohort. J Geriatr Oncol 11:586–592. https://doi.org/10.1016/j.jgo.2019.07.023
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Early follow-up of outpatients with oral anticancer therapy in the ONCORAL multidisciplinary community-hospital program;The Oncologist;2024-09-14
2. Herb-antitumour drug interaction risks: retrospective integrative oncology study;BMJ Supportive & Palliative Care;2024-08-13
3. Optimal hyperglycemia thresholds in patients undergoing chemotherapy: a cross sectional study of oncologists’ practices;Supportive Care in Cancer;2024-08
4. Clinical Pharmacy Initiatives Contribute to the Excellent Efficacy of the Dabrafenib/Trametinib Combination for Iodine-Refractory Thyroid Carcinoma: A Case Report;Medicina;2024-06-25
5. Antineoplastic Therapy Administration Safety Standards for Adult and Pediatric Oncology: ASCO-ONS Standards;Oncology Nursing Forum;2024-05-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3